verucerfont drug developed glaxosmithkline acts antagonist corticotropin releasing factor crf also known corticotropin releasing hormone endogenous peptide hormone released response various triggers chronic stress activates two corticotropinreleasing hormone receptors triggers release corticotropin acth another hormone involved physiological response stress verucerfont blocks receptor reduces acth release following chronic stress investigation potential treatment alcoholism chronic stress often factor development alcoholism relapse recovering alcoholics shown promising results animal however human trials shown neuroendocrine effects translate animal models alcohol anticraving effects httpsenwikipediaorgwikiverucerfont